Use of Anti-VEGF Agents in Glaucoma Surgery
A number of antivascular endothelial growth factor agents are currently used to treat ocular conditions. These agents have similar but distinct biologic qualities and have each been used in the management of neovascular glaucoma and in glaucoma surgery. Several different delivery methods are describ...
Saved in:
Main Authors: | Mark Slabaugh, Sarwat Salim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2017/1645269 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability
by: Kenichi Kimoto, et al.
Published: (2012-01-01) -
Human Platelets Take up Anti-VEGF Agents
by: B. Sobolewska, et al.
Published: (2021-01-01) -
Anti-VEGF agents for the treatment of diabetic macular edema
by: S.G. Sergushev, et al.
Published: (2019-11-01) -
Effectiveness and tolerability of the combined use of anti-VEGF agents in clinical practice
by: A.V. Kuroyedov, et al.
Published: (2020-11-01) -
Outcomes of 23-Gauge Vitrectomy Combined with Phacoemulsification, Panretinal Photocoagulation, and Trabeculectomy without Use of Anti-VEGF Agents for Neovascular Glaucoma with Vitreous Hemorrhage
by: Hua Yan
Published: (2016-01-01)